ProPhase Labs, Inc.

PRPHOTCCIK 868278HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 400 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

ProPhase Labs, Inc., Reports and events
Filed	Form	What it is	Accession number
2021-04-1616:56 ET	DEF 14A	Proxy statementPeriod 2021-04-16	0001493152-21-008994
2021-04-0512:51 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-007936
2021-03-3121:25 ET	10-K	Annual reportPeriod 2020-12-31	0001493152-21-007538
2021-03-1715:57 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-006226
2021-02-0113:35 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-21-002173
2021-01-2021:15 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-21-001435
2021-01-1512:46 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001493152-21-001124
2021-01-0713:05 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-21-000410
2021-01-0421:30 ET	8-K/A	9.01 Financial statements and exhibits	0001493152-21-000072
2020-12-1621:30 ET	8-K	1.02 Termination of a material agreement	0001493152-20-023760
2020-12-1521:30 ET	8-K	5.02 Departure or appointment of officers or directors	0001493152-20-023645
2020-12-1421:36 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001493152-20-023541
2020-12-1411:11 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-023458
2020-11-1922:01 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001493152-20-022041
2020-11-1613:35 ET	8-K	2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-20-021438
2020-11-1013:35 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-020874
2020-10-2620:15 ET	8-K	1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-019947
2020-10-0610:08 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-018968
2020-09-3020:59 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-018633
2020-09-2320:15 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-018228
2020-09-1812:05 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-20-017997
2020-09-1120:15 ET	8-K	8.01 Other events	0001493152-20-017637
2020-08-2520:07 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001493152-20-016677
2020-08-1720:30 ET	SC 13D/A	Ownership report, active investor, amended	0001493152-20-016098
2020-08-1121:00 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001493152-20-015271
2020-08-1113:08 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-20-015196
2020-05-2200:52 ET	8-K	5.07 Shareholder vote results	0001493152-20-009667
2020-05-1401:41 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-20-008574
2020-05-1220:57 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001493152-20-008391
2020-04-1620:20 ET	DEF 14A	Proxy statementPeriod 2020-04-16	0001493152-20-006542
2020-03-3012:00 ET	SC 13D/A	Ownership report, active investor, amended	0001493152-20-005024
2020-03-2712:27 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-20-004862
2020-03-2620:31 ET	10-K	Annual reportPeriod 2019-12-31	0001493152-20-004807
2019-11-2521:15 ET	8-K	5.02 Departure or appointment of officers or directors	0001493152-19-018354
2019-11-2021:20 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-19-018118
2019-11-1222:09 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-19-016938
2019-11-1220:54 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001493152-19-016884
2019-08-1219:53 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001493152-19-012065
2019-08-1212:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-19-012034
2019-06-0311:00 ET	8-K	8.01 Other events	0001493152-19-008529
2019-05-2420:15 ET	8-K	5.07 Shareholder vote results; 8.01 Other events	0001493152-19-008241
2019-05-1521:53 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-19-007141
2019-05-1420:31 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001493152-19-007096
2019-04-1922:54 ET	DEF 14A	Proxy statementPeriod 2019-04-18	0001493152-19-005646
2019-03-2620:46 ET	10-K	Annual reportPeriod 2018-12-31	0001493152-19-003946
2019-03-2612:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-19-003899
2019-01-1823:12 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001493152-19-000748
2018-12-2722:46 ET	8-K	3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-18-017964
2018-11-1419:04 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001493152-18-015980
2018-08-2110:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-18-012403

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.